FREEDOM LEAF, INC - FRLF OTCQB TARGET $0.22

Leading Cannabis News Publication

Top Marijuana Stocks - FRLF Management Discussion 6 Mos Results

Opens Research Facilities In Europe - Stock Triples In 60 Days 

This stock has more than tripled in the past month climbing to $0.11 on very high volume . FRLF is worth watching for any pullback giving our subscribers opportunities to step up and purchase these shares.

A recent research report on FRLF has been issued by by Wall Street Research . The report highlights the company's superior editorial team and products and recommends the purchase of the shares

Read This Report  http://wallstreetresearch.org/reports/FRLF-Aug-2017.pdf

We expect these shares to test that level and we place our short term target price at $0.22


Fact Sheet - Magazine

Freedom Leaf, Inc. Completes 100% Acquisition of Spanish Hemp Producer, Green Market Europe S.L., Further Driving Revenue and Building Shareholder Value for (OTCQB: FRLF)

Our philosophy is to only acquire companies that will add significant Gross Revenue, Net Profit and Shareholder Value to FRLF

LAS VEGAS, NV, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Freedom Leaf Inc. ® (OTCQB:FRLF), The Marijuana Legalization Company ®, is pleased to report that it has fully acquired 100% of Green Market Europe S.L.(GME), a Spanish producer of hemp products. Since the announcement of the acquisition, June 28th 2017, Freedom Leaf Inc. Officers have been diligently working to finalize the international acquisition, and as of today all relevant documentation has been submitted, signed, and finalized.

Clifford J. Perry, Co-founder and CEO of Freedom Leaf Inc., said, “We are very pleased to have completed this transaction, the deal is now final. Our philosophy is to only acquire companies that will add significant Gross Revenue, Net Profit and Shareholder Value to Freedom Leaf Inc. financials, and this is no exception. Green Market Europe S.L. is projected to add €2.000.000 ($2,393,060USD) in its first full year of operation at approximately a 15% net profit.”

Green Market Europe S.L. facilities include a 21,000 sq. ft. light deprivation greenhouse, a 43,000 sq. ft. indoor growing research facility, and over 200 acres of outdoor production space. The light deprivation allows the increase of the number of yearly crops from 3 to 4 crops a year, and the 43,000 sq. ft. indoor grow facility is used for genetic research and cultivating additional hemp crops. Green Market Europe S.L. is strategically located in Elche, Alicante, an important Spanish business hub, with great year-round weather conditions for agricultural growing and a long tradition of growing hemp.

GME marks the second completed acquisition for Freedom Leaf Inc. in Spain and Europe. The first acquisition was in May 2017 of LaMarihuana.com, the Spanish-speaking community’s leading cannabis portal, and Marihuana-Medicinal.com, an influential Spanish medical cannabis information website. LaMarihuana.com was founded in 2001 and currently has more than 1.7 million page visits monthly, making it the among the most visited online portals worldwide for the Spanish-speaking community. LaMarihuana.com also has more than 1.3 million Facebook fans.

Freedom Leaf, Inc. is currently collaborating with Spanish scientists isolating other rare cannabinoids. Some of the ongoing research includes strains with Tetrahydrocannabivarin (THCV), which suppresses appetite, and Cannabichromene (CBC), which has been shown to aid with depression.

Perry has hailed Freedom Leaf Iberia B. V. licensee’s Managing Director, Federico Pando, for his work in bringing this and other Spanish projects to fruition for Freedom Leaf Inc.

¨GME will be an essential tool of FL to expand in the Medical Cannabis and cannabinoid based therapy. The know-how of mass Cannabinoid production, research and IP gives us a priceless competitive advantage towards cooperating with Governments and Institutions to bring Cannabinoid based therapy to medical patients,” stated by Federico Pando.

Paul F. Pelosi, Jr., Freedom Leaf Inc Chairman of the Board, added, “Freedom Leaf is staking its claim to foreign markets. Starting with Europe and planning for Central and South America expansion as well as other countries around the world. The market for Industrial Hemp is expanding in many countries even faster than the United States, and in many cases even faster than marijuana. Major legal revenue streams are available from exploring these different markets around the world.”

Green Market Europe S.L. has a current collaboration agreement with Elche-based University of Miguel Hernandez to grow and develop EU certified Hemp strains with high cannabidiol (CBD) content that can easily grow in the local climate, and for researching better methods for growing hemp.

The company is also collaborating with two privately owned European companies for product development and global marketing to provide a variety of Freedom Leaf branded products with Rare Cannabinoids, CBG, (Cannabigerol) in addition to its popular CBD, Cannabidiol. Other rare cannabinoids are also being developed

Although NO MEDICAL CLAIMS ARE BEING MADE  FOR ANY OF THE PRODUCTS, in various studies there are indications that Cannabigerol may relieve pain, reduce seizures and convulsions, slow bacterial growth in certain species, reduce inflammation systemically, induce sleep, inhibit cancer cell growth, stimulate the growth of new brain cells and promote bone growth. Some of the other conditions under study include glaucoma, inflammatory bowel diseases, anti-inflammatory disorders, epilepsy and chronic pain.

About Freedom Leaf

Freedom Leaf, Inc., The Marijuana Legalization Company®, is a fully reporting and audited, publicly traded company trading under the symbol (OTCQB: FRLF). Freedom Leaf, Inc. is a leading go-to resource in the cannabis, medical marijuana, and industrial hemp industry. It is involved in mergers and acquisitions and business consulting in the marijuana industry, including incubation/acceleration and spin offs of new marijuana/hemp related companies.

Freedom Leaf, Inc.’s flagship publication is Freedom Leaf Magazine, “The Good News in Marijuana Reform.” The company produces a portfolio of news, print and digital multi-media verticals, websites, blogs and web advertising, for the ever-changing emerging cannabis, medical marijuana and industrial hemp industry.

Freedom Leaf, Inc. does not handle, grow, sell, or dispense marijuana.

All of our European activities are in full compliance with relevant EU laws.

 

Sessions' "New Policy" Not "New" and Not Threat to Freedom Leaf, Inc. (OTCQB: FRLF)

The Marijuana Legalization Company More Relevant Than Ever; The Important Role of Informed Investors Conservative Republicans Strongly Object

LAS VEGAS, NV, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Clifford J. Perry and Richard Cowan, Co-Founders of Freedom Leaf, Inc., "The Marijuana Legalization Company®" (OTCQB: FRLF), a group of diversified, international, vertically-integrated Cannabis/Hemp businesses and media companies, issued a statement today noting that Attorney General Jeff Sessions’ supposedly “new” marijuana policy is no threat to FRLF, which is compliant with all relevant laws, in the U. S. and Europe.

Freedom Leaf CEO, Clifford J. Perry, explained, “We believe that The Marijuana Legalization Company® has an important role to play in educating marijuana investors and the extreme volatility of Cannabis related shares over the last few days illustrates that point. While we are very grateful for the buying in FRLF shares following legalization in California, the fact is that it will have little or no impact on FRLF as we do not handle, grow, sell, or dispense marijuana, but neither will Sessions’s threats, which sparked a sell-off in our shares.”

Richard Cowan, a former Executive Director of NORML (National Organization for the Reform of Marijuana Laws), a long time marijuana author and activist, noted that there is really nothing new in Sessions’ statement because, when he first became Attorney General, he said, “We should enforce the laws as we are able.” That is really all that yesterday’s DoJ memo “announcing a return to the rule of law and the rescission of previous guidance documents” said.

Cowan explained, “The Federal Government simply does not have the resources to suppress America’s booming cannabis industries. If they couldn’t stop it 20 years ago, when it was in its infancy, they certainly can’t stop it now.

“Sessions’s statement may have been intended to satisfy his Prohibitionist friends, but unfortunately, it was so vague that it is also a threat to medical marijuana laws, which are supported by over 80% in national polls and which candidate Trump promised to uphold.”

Cowan noted, “Marijuana Legalization was the only clear winner in the 2016 elections, and we beat the Drug Warriors in every state, except one out of the eight on the ballot. In Arizona, recreational legalization lost with 46.68%, where President Trump won with 49.5%.

“Sessions is reportedly already ‘on thin ice’ with the President, so the timing of this announcement is puzzling. After these overwhelming victories for the marijuana movement. No one has a mandate to oppose the will of the people that was so clearly expressed in these elections.”

Cowan also noted that many of the states where the people voted for marijuana reform (in 2016 or before) also have Republican Senators: Alaska (2), Arkansas (2), Colorado (1), Florida (1), where Marco Rubio won reelection with 51.9% and medical marijuana got 71.32%, Maine (1), Montana (1), Nevada (1), North Dakota (1). Nevada Republican Senator Dean Heller is up for reelection this year and is considered especially vulnerable.

Moreover, Gallup reports that over 60% of Americans now support marijuana legalization, whereas President Elect Trump got less than 48% of the popular vote. Nonetheless, there has been a rash of alarmist articles about how the Trump administration might somehow block the clear will of the people, but they rarely consider the blowback from such a policy reversal, especially from Republicans.

Twenty-eight states and Washington, D.C., allow marijuana for medical or recreational purposes. “Will they represent their voters or the DEA?" Cowan asked. The answer came immediately.

Yesterday, Colorado senator Cory Gardner, chairman of the National Republican Senatorial Committee, that funds GOP Senatorial candidates and is consequently very influential in the 2018 midterm elections, is especially angry. He told reporters last winter that he would vote to confirm Sessions as Attorney General only after securing Sessions' word that the Justice Department would not interfere with state-level decisions about marijuana policy.

Gardner Tweeted: "I will be putting today a hold on every single nomination from the Dept. of Justice until Attorney General Jeff Sessions lives up to the commitment that he made to me on legalized marijuana in Colorado.”

Other conservative Republicans with ties to President Trump also denounced Sessions’ action. Orange County Republican Representative Dana Rohrabacher, an old friend of both Trump and Sessions, issued a press release saying, “The attorney general of the United States has just delivered an extravagant holiday gift to the drug cartels. By attacking the will of the American people, who overwhelmingly favor marijuana legalization, Jeff Sessions has shown a preference for allowing all commerce in marijuana to take place in the black market, which will inevitably bring the spike in violence he mistakenly attributes to marijuana itself. He is doing the bidding of an out-of-date law enforcement establishment that wants to wage a perpetual weed war and seize private citizens’ property in order to finance its backward ambitions.

“This is a profound misreading of the Constitution, which allows states, not the heavy-handed federal government, to determine such issues. How ironic that the attorney general has long championed states’ rights when it suits other parts of his agenda! More than that, by attacking the clear will of the American people, the attorney general contradicts President Trump’s campaign pledges to leave medical and recreational marijuana questions for the states to decide. By taking this benighted minority position, he actually places Republicans’ electoral fortunes in jeopardy.”

 

 

 

Forward and Cautionary Statement - Disclaimer

About Marijuana Stock Reporting.net 

MarijuanaStockReporting.net
 is a subsidiary of Target Publishing Inc, and is a leading publisher of todays market and investment news, commentary, proprietary research and videos from seasoned journalists, analysts and contributors covering the financial markets and global economies. We have been paid by a third party to wite this article  Leveraging our extensive distribution network and social media presence, we have cultivated a valuable audience of engaged market enthusiasts, which in turn delivers a variety of unique oppXortunities for industry partnerships, corporate communications, market exposure and investment. The article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility.

A complete disclaimer can be viewed 
HERE